摘要
国际癌症报告联盟(International Collaboration on Cancer Reporting,ICCR)专家组最近报道了甲状腺规范化报告病理数据集,包括核心元素和非核心元素。该规范化报告使用了2017年世界卫生组织(World Health Organization,WHO)的最新甲状腺肿瘤分类,进一步强调了根据血管和甲状腺外浸润范围将患者进行危险分层以获得更佳治疗的重要性。首次要求病理科医师将核分裂象和肿瘤坏死2个独立参数纳入规范化报告。重申评估转移性淋巴结体积对预测复发风险的重要性。ICCR甲状腺规范化报告可辅助生成病理报告,以更合理的方式指导患者的治疗,防止对致死性恶性肿瘤的治疗不足,并且为惰性肿瘤患者免去不必要的治疗。
Data set for reporting carcinoma of thyroid was summarized by the International Collaboration on Cancer Reporting(ICCR),including core elements and non-core elements.The data set uses recent World Health Organization(WHO)classification of thyroid tumors to get the clinical and prognostical nomenclature.It further highlights the importance of risk stratification according to the vascular invasion and extrathyroidal extension for the patients.It is by far the first data set to include mitotic activity and tumor necrosis as two independent parameters for reporting carcinoma of the thyroid.It further emphasizes the importance of evaluating the volume of metastasis of the lymph nodes on recurrence risk stratification.The ICCR thyroid data set help generating a report to lead a more rationale therapy and avoid incomplete therapy for lethal tumors and unnecessary treatment for indolent tumors.
作者
刘志艳
王馨培
LIU Zhiyan;WANG Xinpei(Department of Pathology,Shanghai Jiao Tong University Affiliated Sixth People’s Hospital,Shanghai 200233,China;Department of Pathology,Shandong University School of Basic Medical Sciences,Jinan 250012,Shandong Province,China)
出处
《肿瘤》
CAS
CSCD
北大核心
2022年第1期44-52,共9页
Tumor
基金
山东省自然科学基金面上项目(ZR2019MH024)
国家自然科学基金面上项目(81972500)
关键词
甲状腺癌
病理参数
国际癌症报告联盟
解读
Thyroid cancer
Pathologic parameters
International Collaboration on Cancer Reporting
Interpretation